The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction

What this Trial Is About

Researchers are collecting performance and safety information for Medtronic devices that are already available on the market and used for cranial or spinal conditions. The study focuses on people who receive these devices for spinal deformities, degenerative disorders, fusion failure, trauma, or tumors. It aims to gather data that aligns with regular clinical care to better understand how these devices work in real-world settings. Participants will receive one or more eligible Medtronic Cranial and Spinal Technology devices, which may include powered systems, instruments, imaging devices, advanced energy devices, robotics and navigation tools, rods and screws, interbodies and biologics, spinal tethers, or other spinal hardware. The study involves follow-up assessments from before surgery through 24 months after the procedure to monitor device performance and surgical outcomes. During the study, participants will undergo various evaluations including surgical success within 14 days post-operation, fusion success at 12 months, device performance up to 24 months, pain resolution, stabilization, and deformity correction depending on the devices used. Follow-up visits include assessments consistent with routine care, and safety is monitored by tracking device-related adverse events over 24 months. The total participation duration is up to two years.

The Ailliance Post-Market Clinical Study